United States · FDA National Drug Code directory

Moderna COVID-19 Vaccine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 50024-300_326f7b04-533b-1863-e063-6294a90a19da
Product NDC: 50024-300
Form: INJECTION, SUSPENSION
Composition / generic term: Moderna COVID-19 Vaccine
Labeler: ROVI Pharma Industrial Services S.A.
Marketing category: DRUG FOR FURTHER PROCESSING
Marketing start / end (source format): 20240820
Source listing expiry: 20261231

Source-listed ingredients

CX-046684 — 25 ug/.25mL

These values do not establish equivalence or a dose recommendation.

Packages

10 SYRINGE, PLASTIC in 1 CARTON (50024-300-01) / .25 mL in 1 SYRINGE, PLASTIC (50024-300-02) · 50024-300-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →